We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

141 hedge funds and large institutions have $122M invested in Heron Therapeutics in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

8,544% more call options, than puts

Call options by funds: $1.38M | Put options by funds: $16K

6% more capital invested

Capital invested by funds: $115M → $122M (+$7.21M)

1.54% more ownership

Funds ownership: 82.56% → 84.11% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

7% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 41

5% less funds holding

Funds holding: 149 → 141 (-8)

26% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 19

Holders
141
Holders Change
-8
Holders Change %
-5.37%
% of All Funds
2.24%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
38
Reduced
41
Closed
19
Calls
$1.38M
Puts
$16K
Net Calls
+$1.37M
Net Calls Change
+$1.41M

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$21.3M
2
CC
Clearline Capital
New York
+$4.96M
3
VCIM
Velan Capital Investment Management
Georgia
+$3.54M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.42M
5
OCM
Orchard Capital Management
Illinois
+$1.07M

Top Sellers

Rank Fund Capital Flow
1
JFG
Jefferies Financial Group
New York
-$1.5M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.09M
3
Franklin Resources
Franklin Resources
California
-$712K
4
Citadel Advisors
Citadel Advisors
Florida
-$606K
5
XT
XTX Topco
Cayman Islands
-$473K
Name Holding Trade Value Shares
Change 		Change in
Stake
ISL
101
Ingalls & Snyder LLC
New York
$12K – – –
QT
102
Quantbot Technologies
New York
$11.3K +$15.6K +10,992 New
HighTower Advisors
103
HighTower Advisors
Illinois
$11K +$15.3K +10,760 New
VWM
104
Venturi Wealth Management
Texas
$10.8K -$413 -290 -3%
Citadel Advisors
105
Citadel Advisors
Florida
$10.7K -$606K -425,601 -98%
Envestnet Asset Management
106
Envestnet Asset Management
Illinois
$10.4K +$14.4K +10,132 New
DLA
107
Douglas Lane & Associates
New York
$10.3K – – –
AIP
108
Ameritas Investment Partners
Nebraska
$7.34K – – –
JEST
109
JTC Employer Solutions Trustee
Jersey
$7K – – –
CA
110
Clearstead Advisors
Ohio
$6.59K +$4.55K +3,200 +100%
MLICM
111
Metropolitan Life Insurance Company (MetLife)
New York
$6.35K +$666 +468 +8%
Qube Research & Technologies (QRT)
112
Qube Research & Technologies (QRT)
United Kingdom
$6.2K +$8.57K +6,021 New
WWP
113
WR Wealth Planners
Missouri
$3.91K – – –
GRP
114
Global Retirement Partners
California
$3.84K – – –
NA
115
NewEdge Advisors
Louisiana
$2.88K – – –
BEI
116
Benjamin Edwards Inc
Missouri
$2K – – –
CG
117
Cutler Group
California
$2K – – –
PNC Financial Services Group
118
PNC Financial Services Group
Pennsylvania
$1.76K – – –
CFGS
119
Concourse Financial Group Securities
Alabama
$1.63K -$36 -25 -2%
Nisa Investment Advisors
120
Nisa Investment Advisors
Missouri
$1.12K – – –
SPIA
121
Steward Partners Investment Advisory
New York
$1.03K – – –
BCV
122
Banque Cantonale Vaudoise
Switzerland
$1K – – –
WAS
123
Winch Advisory Services
Wisconsin
$1K – – –
KT
124
Kevin Tang
$783 – – –
National Bank of Canada
125
National Bank of Canada
Quebec, Canada
$586 – – –
3 4
5
6 7

HRTX Hedge Fund Activity: Q3 2023 in Review

141 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2023, worth a combined $122M — up 6.3% from $115M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of HRTX and 14 opened new positions — a net loss of 5 holders — while 41 trimmed existing stakes and 38 added.

The largest buyer was Rubric Capital Management (New York), adding an estimated $21.3M. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $1.5M sold.

  • 141 institutional investors held Heron Therapeutics (HRTX) as of Q3 2023, down from 149 in Q2 2023.
  • Funds reported $122M of Heron Therapeutics stock for Q3 2023, up 6.3% quarter-over-quarter.
  • 14 funds opened new Heron Therapeutics positions in Q3 2023 and 19 closed out, a net change of -5 holders.
  • The largest Heron Therapeutics buyer in Q3 2023 was Rubric Capital Management (New York), an estimated $21.3M added.
  • The largest Heron Therapeutics seller in Q3 2023 was Jefferies Financial Group, an estimated $1.5M sold.

Based on aggregated 13F filings for Q3 2023.